What triggered the US-China 90-day tariff truce?
How will Trump's drug price executive order affect pharma?
Why is Tesla stock surging after trade talks?
What impact will GM's ex-Tesla exec hire have?
How is US-China tariff pause influencing markets?
Why is Nissan doubling planned job cuts?
What concerns surround Trump's acceptance of Qatar's jet?
How are US small businesses coping with tariffs?
What does the new US immigration reform propose?
FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients
benzinga.com/general/biotech/25/05/45345633/exclusive-fda-clears-lantern-pharmas-planned-phase-1b-2-trial-of-lp-184-in-treatment-resistant-lu
The U.S. Food and Drug Administration (FDA) on Monday cleared the amendment to Lantern Pharma Inc.’s (NASDAQ:LTRN) Investigational New Drug (IND) application for the Phase 1b/2 trial of LP-184 in a genomically defined patient population of non-small cell lung cancer (NSCLC).
The…
This story appeared on benzinga.com, 2025-05-12 12:31:40.